Philly’s Carisma Therapeutics slashed its workforce to 6 from 46 for sale or wind down
The University of Pennsylvania spinout said it has no intention to resume research and development work. To continue reading ...
Carisma Therapeutics price target lowered to $1 from $12 at D. Boral Capital
D. Boral Capital lowered the firm’s price target on Carisma Therapeutics (CARM) to $1 from $12 and keeps a Buy rating on the shares after the ...
Kazia Therapeutics sells IP, trademarks rights to Cantrixil for $1M
Kazia Therapeutics (KZIA) announced the sale of all intellectual property and trademarks rights to Cantrixil for $1M. In March 2021, Vivesto ...
Medindia18d
Skyhawk Therapeutics Presents at Huntington's Disease Youth Organization HDYO International Congress 2025
BOSTON, March 15, 2025 /PRNewswire/ -- Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets ...
Seeking Alpha22d
Viking Therapeutics: Signs Of Insufficient Differentiation In Obesity Treatment (Rating Downgrade)
Viking Therapeutics' stock declined by 37% following a downgrade to "hold" in December, anticipating competitive pressures from Novo Nordisk's CagriSema Phase 3 results. The company's GIP/GLP-1 ...
inkbotdesign.com23d
The Apple Logo History, Meaning and Evolution
From its origins in a garage to becoming one of the most recognisable symbols in the world, explore the story behind the iconic Apple logo design. Apple is a company that has changed the technology ...
FiercePharma23d
On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of ...